Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections

Research output: Contribution to journalArticle

Abstract

The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.

Original languageEnglish (US)
Pages (from-to)283-288
Number of pages6
JournalDrugs of the Future
Volume43
Issue number4
DOIs
StatePublished - Jan 1 2018

Keywords

  • ALT-803
  • Lefitolimod
  • MB66
  • Novel formulations
  • Pembrolizumab
  • VRC07-523LS

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections'. Together they form a unique fingerprint.

  • Cite this